$NBIX Recent News Biogen, Constellation gain; Family

New Post Public Reply Private Reply Replies (0) Message Board

Jan 8, 2015 at 10:15 AM

$NBIX Recent News

Biogen, Constellation gain; Family Dollar, Alexion drop 47 min ago - MarketWatch
Banks, hedge funds and what Citi has to tell its rich clients 7:47 a.m. Jan. 13, 2014 - Shawn Langlois
Stock futures gain as S&P 500 looks to halt skid 8:59 a.m. Jan. 7, 2014 - Victor Reklaitis
Yahoo, Palo Alto, Neurocrine are stocks to watch 5:31 a.m. Jan. 7, 2014 - Wallace Witkowski
Palo Alto, Convergys shares rise on acquisitions 5:08 p.m. Jan. 6, 2014 - Wallace Witkowski
Neurocrine Biosciences shares jump 60% on study 4:51 p.m. Jan. 6, 2014 - Wallace Witkowski
Neurocrine Biosciences shares surge on study 4:50 p.m. Jan. 6, 2014 - MarketWatch.com
S&P’s 50-day average remains the technical test 10:10 a.m. July 1, 2013 - Michael Ashbaugh
Volatility spike supports bullish market view 11:07 a.m. June 4, 2013 - Michael Ashbaugh
Volatility spike supports bullish market view 10:59 a.m. June 4, 2013 - Michael Ashbaugh
In focus: Bears trying to gain traction 6:30 p.m. May 29, 2013 - Lawrence G. McMillan
In focus: Awaiting the next move 7:57 p.m. Feb. 6, 2013 - Lawrence G. McMillan
Neurocrine to offer 9.5 mln shares 10:02 a.m. Jan. 19, 2012 - MarketWatch.com
Inspire, Questcor lead drug stocks north 2:55 p.m. April 5, 2011 - Val Brickates Kennedy
Neurocrine climbs on drug update 10:50 a.m. April 5, 2011 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:31 p.m. Feb. 11, 2011 - Kate Gibson
Mannkind sinks in mixed drug sector 3:20 p.m. Feb. 11, 2011 - Val Brickates Kennedy
Drug stocks inch higher; Cytori slides 2:34 p.m. Oct. 8, 2010 - Val Brickates Kennedy
Neurocrine shares jump on analyst rating 9:07 a.m. Oct. 8, 2010 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:26 p.m. Sept. 15, 2010 - MarketWatch

Neurocrine Bio up on positive Phase 3 results 8:59 a.m. Today - Seeking Alpha
Hottest Healthcare Stocks Now – HALO NBIX AMAG ENDP 5:45 a.m. Jan. 7, 2015 - InvestorPlace.com
Our 3 Best Performing Stocks Of 2014 6:52 p.m. Jan. 5, 2015 - Seeking Alpha
15 Biotech Names For 2015 2:37 p.m. Jan. 5, 2015 - Seeking Alpha
What Investors Expect From Neurocrine Biosciences' Next Drug Announcement 1:53 p.m. Jan. 2, 2015 - benzinga.com
Biggest Movers in Healthcare Stocks Now – QGEN BABY ISRG REGN 12:45 p.m. Dec. 31, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ISIS NBIX CLDX EXAS 6:15 a.m. Dec. 26, 2014 - InvestorPlace.com
Commit To Buy Neurocrine Biosciences At $17, Earn 30.2% Annualized Using Options 12:18 p.m. Dec. 24, 2014 - TheStreet.com
5 Stocks With Ugly Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 2:15 a.m. Dec. 22, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – NLNK MACK ELGX HZNP 3:00 p.m. Dec. 19, 2014 - InvestorPlace.com
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know 9:20 a.m. Dec. 17, 2014 - TheStreet.com
Auspex Drug Reduces Uncontrolled Movements in Huntington's Patients 4:06 p.m. Dec. 16, 2014 - TheStreet.com
5 Stocks With Poor Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 2:00 a.m. Dec. 15, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – NBIX TECH AZN ISIS 7:30 a.m. Dec. 10, 2014 - InvestorPlace.com
Neurocrine Biosciences Reports Expansion of Clinical Pipeline 7:02 a.m. Dec. 10, 2014 - benzinga.com
5 Stocks With Ugly Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 2:00 a.m. Dec. 8, 2014 - InvestorPlace.com
5 Stocks With Crummy Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 4:00 a.m. Dec. 1, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – NLNK PTCT VRTX LUX 6:30 a.m. Nov. 28, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – NBIX MWIV BABY NPSP 1:15 p.m. Nov. 24, 2014 - InvestorPlace.com
5 Stocks With Poor Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 2:45 a.m. Nov. 24, 2014 - InvestorPlace.com

AbbVie Announces Positive Top-Line Results From Phase 3 Study of Investigational Medicine Elagolix in Patients with Endometriosis 8:00 a.m. Today - PR Newswire - PRF
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio 8:50 a.m. Dec. 12, 2014 - PR Newswire - PRF
Just Released: New Research on American Airlines, Staples, Cyren, Neurocrine Biosciences, and Cherokee 9:17 a.m. Dec. 11, 2014 - PR Newswire - PRF
Neurocrine Biosciences Announces Expansion of its Clinical Pipeline 8:00 a.m. Dec. 10, 2014 - PR Newswire - PRF
Neurocrine Biosciences to Present at the 25th Annual Oppenheimer Healthcare Conference 7:00 p.m. Dec. 4, 2014 - PR Newswire - PRF
Neurocrine to Present at the 2014 Deutsche Bank BioFEST and the 26th Annual Piper Jaffray Healthcare Conference 1:00 p.m. Nov. 25, 2014 - PR Newswire - PRF
Retrophin Names Margaret Valeur-Jensen, Ph.D. as General Counsel 8:01 a.m. Nov. 19, 2014 - BusinessWire - BZX
Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference 1:56 p.m. Nov. 12, 2014 - PR Newswire - PRF
Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference 1:00 p.m. Nov. 12, 2014 - PR Newswire - PRF
Neurocrine Biosciences, Inc. Announces Appointment of Darin Lippoldt as Chief Legal Officer 7:30 a.m. Nov. 4, 2014 - PR Newswire - PRF
Neurocrine Biosciences to Present at the Nomura Biotechnology Conference 7:00 p.m. Nov. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Reports Third Quarter 2014 Results 4:01 p.m. Nov. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia 6:30 a.m. Oct. 30, 2014 - PR Newswire - PRF
Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2014 Financial Results 3:05 p.m. Oct. 27, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 7:35 a.m. Oct. 27, 2014 - PR Newswire - PRF
Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854 3:05 p.m. Oct. 20, 2014 - PR Newswire - PRF
Neurocrine Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study 3:02 p.m. Oct. 2, 2014 - PR Newswire - PRF
Neurocrine Biosciences, Inc. Announces Appointment of Malcolm Lloyd-Smith as Chief Regulatory Officer 4:20 p.m. Oct. 1, 2014 - PR Newswire - PRF
Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference 12:00 p.m. Sept. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Reports Second Quarter 2014 Results 3:02 p.m. Aug. 6, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OncoHost's Research Links TKI Sensitivity to Biology

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Tennessee's Bold Lung Cancer Trial Signals Innovation

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

111, Inc. Strategizes with Advisors Amid Proposal Talks

Every time a company's board starts tossing around phrases like "strategic alternatives," you’ve got to pay closer attention. 111, Inc., holding the NASDAQ ticker YI, is one such entity at a crossroads. They've enlisted Houlihan Lokey China Limited as their independent financial advisor and Kirkland & Ellis as their U.S. legal counsel to sift through potential strategic...

Linkurious Named Category Leader in AML Monitoring

Graph Intelligence: The Winning Edge You know, the financial crime scene ain't what it used to be. Gone are the days when a simple audit trail was enough to sniff out dirty money. Companies like Linkurious are pushing the envelope with graph-powered decision intelligence, and in 2026, they got the nod from Chartis Research as a Category Leader for AML Transaction...

FL Technics Indonesia Expands with EASA Certification

Bali's Skies Just Got a Major Upgrade Picture this: You've got a sprawling 17,000 square meter facility sitting pretty at I Gusti Ngurah Rai International Airport, nestled in the paradise locale of Bali. What's next? It's now flexing some serious muscles with its newfound EASA Part-145 certification, allowing it to tackle aircraft registered in the European Union. This is...

EQT Acquires Range Resources: Redefining Gas Markets

A New Chapter in Natural Gas Who would have thought? EQT Corporation, that sturdy old veteran in the natural gas game, finally made its move and snatched up Range Resources, sprinting right out of left field. This merger isn't just about two companies shaking hands; it's about rewriting the entire narrative of America's natural gas landscape. With this acquisition, EQT's...

Redwood and SAP Partner on Secure File Transfer

Redwood Advances SAP Interiors with New File Solution October 26, '26 is now a landmark for Redwood Software. They've just rolled out their SAP Managed File Transfer solution. Got the brainpower behind Redwood and SAP operating together here, and they're offering this to enterprises aimed at optimizing their file-based workflow. If you're scratching your head just hearing...

CStone's CS2009: A Leap in Cancer Treatment Validated

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

DropGenie Nets $5M to Boost Functional Biology Reach

DropGenie Scores Big with Fresh Financing Boost Out of the Montreal wilderness, DropGenie is charging forward with a fresh $5 million injection in Seed+ financing. This isn't just loose change; it's a ticket to accelerating their mission of advancing functional biology platforms and beefing up data partnerships. You know, the kind of partnerships that even the suits in...